The relevance of SCD1, MVK, FASN and DHCR24 in melanoma progression or drug resistance is already supported by our previous studies and by the literature (Pisanu et al., 2018; Theodosakis et al., 2019; Stamatakos et al., 2021). This evidence concerns the gene DHCR24 and melanoma.